biostudies-literatureUnknown8(1)OnCovid Study Group<h4>Importance</h4>Whether the severity and mortality of COVID-19 in patients with cancer have improved in terms of disease management and capacity is yet to be defined.<h4>Objective</h4>To test whether severity and mortality from COVID-19 among patients with cancer have improved during the course of the pandemic.<h4>Design, setting, and participants</h4>OnCovid is a European registry that collects data on consecutive patients with solid or hematologic cancer and COVID-19. This multicenter case series study included real-world data from 35 institutions across 6 countries (UK, Italy, Spain, France, Belgium, and Germany). This update included patients diagnosed between February 27, 2020, and February, 14, 2021. Inclusion criteria were confirmed diagnosis of SARS-CoV-2 infection and a historyJAMA oncology114-122https://www.ebi.ac.uk/biostudies/studies/S-EPMC8777559biostudies-literatureTime-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry.PMC8777559Harbeck NMazzoni FGenerali DQueirolo PPous AFotia VFelip EFerrante DRossi SSegui EPedrazzoli PGuida AMarco-Hernandez JDalla Pria ASureda ASalazar RGiusti RFox LDolly SReyes RNewsom-Davis TRuiz-Camps IPatel MGrisanti SColomba JRussell BColomba ETabernero JSharkey RVincenzi BBerardi RBruna RRoque Lloveras ASita-Lumsden ATondini CMartinez-Vila CSrikandarajah KScotti LDiamantis NEarnshaw IOttaviani DMukherjee UPrat ARizzo GOnCovid Study GroupCarmona-Garcia MCBower MBertuzzi AZoratto FRoldan EFranchi MEvans JSBiello FLambertini MLinan RCortellini AVan Hemelrijck MSaoudi-Gonzalez NBaggi APorzio GPommeret FPatriarca ALoizidou ABrunet JKrengli MAguilar-Company JChiudinelli LParisi AZambelli ATagliamento MSantoro ALibertini MChester JSanchez de Torre AMoss CPinato DJBertulli RCruz CAGennari ARimassa LGaidano GfalseTime-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry.<h4>Importance</h4>Whether the severity and mortality of COVID-19 in patients with cancer have improved in terms of disease management and capacity is yet to be defined.<h4>Objective</h4>To test whether severity and mortality from COVID-19 among patients with cancer have improved during the course of the pandemic.<h4>Design, setting, and participants</h4>OnCovid is a European registry that collects data on consecutive patients with solid or hematologic cancer and COVID-19. This multicenter case series study included real-world data from 35 institutions across 6 countries (UK, Italy, Spain, France, Belgium, and Germany). This update included patients diagnosed between February 27, 2020, and February, 14, 2021. Inclusion criteria were confirmed diagnosis of SARS-CoV-2 infection and a history2022-01-01T00:00:00Z2022 Jan2025-04-25T19:31:05.16Z2025-04-06T08:02:18.237ZS-EPMC87775593481756210.1001/jamaoncol.2021.6199